Consonance Capital Management LP 13D/13G Filings for Aurinia Pharmaceuticals Inc. (AUPH)

Consonance Capital Management LP 13D and 13G filings for Aurinia Pharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-17
2:22 pm
Sale
2020-12-3113GAurinia Pharmaceuticals Inc.
AUPH
Consonance Capital Management LP0
0.000%
-6,058,505decrease
(Position Closed)
Filing
2021-02-16
2:19 pm
Sale
2020-12-3113GAurinia Pharmaceuticals Inc.
AUPH
Consonance Capital Management LP6,058,505
11.000%
-567,166decrease
(-8.56%)
Filing
2020-02-14
1:18 pm
Purchase
2019-12-3113GAurinia Pharmaceuticals Inc.
AUPH
Consonance Capital Management LP6,625,671
3.480%
6,625,671increase
(New Position)
Filing